Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Twist Bioscience Q2 2026 Earnings Call Transcript - Twist Bioscience (NASDAQ:TWST)

The company cited stronger DNA synthesis and NGS demand, along with an AWS partnership and a $17.1 million class-action settlement in principle.

Summary
Twist Bioscience Corporation (NASDAQ:TWST) shares are down on Monday as the company reported its fiscal 2026 second-quarter financial results. The life science company reported an adjusted loss of 59 cents, missing the consensus loss of 48 cents. The sales came in at $110.72 million, beating the consensus of $107.66 million, and the management guidance of $107 million-$108 million. Management Maintains Profitability Timeline “We expect to chart …

3 Articles

BenzingaBenzinga
Center

Twist Bioscience Q2 2026 Earnings Call Transcript - Twist Bioscience (NASDAQ:TWST)

·New York, United States
Read Full Article
Mid Florida NewspapersMid Florida Newspapers
Center

Twist Bioscience: Fiscal Q2 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $44 million in its fiscal second quarter.

Read Full Article
Joplin GlobeJoplin Globe
Center

Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--May 4, 2026-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Joplin Globe broke the news on Monday, May 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

South San Francisco icon

South San Francisco

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal